Explore evidence

48.4 %1693 (48.4%) of the 3501 clients were receiving care in Kisii and Migori counties.

KenyaVIH/sidaobserved between July 2017 and December 2019published 2023AIDS (London, England)PubMeddocument of 5 observations

108.71 USDThe average unit cost per male sex partner (MSP) testing HIV-positive was $108.71.

KenyaVIH/sidapublished 2022BMC health services researchPubMeddocument of 13 observations

704 individualsA total of 704 children living with HIV were followed for 12+ months in Kisumu County, Kenya from 2019 to 2023.

KenyaVIH/sidaobserved 2019 to 2023published 2025VirusesPubMeddocument of 8 observations

89 %Most clients were PrEP-naïve (89%, 737/829).

KenyaVIH/sidapublished 2025Journal of the International AIDS SocietyPubMeddocument of 19 observations

1.13 working_daysIn a point-of-care DRT network, the mean turnaround time ranged from 1.13 to 2.11 working days.

KenyaVIH/sidapublished 2024BMJ openPubMeddocument of 6 observations

437 cells/μlAt the end of the study, the mean CD4 count for HIV mono-infected individuals was 437 cells/μl.

KenyaVIH/sidapublished 2021Pan African Medical JournalOpenAlexdocument of 10 observations

44 %Among HIV-infected women self-reporting pregnancy/live birth, prevalence of viral suppression was 44% at baseline in control communities.

KenyaVIH/sidapublished 2020AIDS (London, England)PubMeddocument of 8 observations

4 %The prevalence of detectable SARS-CoV-2 antibodies was 4% among participants without HIV in Western Kenya.

KenyaCOVID-19 · VIH/sidaobserved January through March 2020published 2021AIDS (London, England)PubMeddocument of 3 observations

2.7 %Among Kenyan adolescents aged 15–19 years in Kisumu who experienced forced sexual contact, 2.7% had used PrEP.

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 15 observations

9.9 %23 (9.9%) patients were infected with drug-resistant HIV strains.

KenyaVIH/sidapublished 2022MedicinePubMeddocument of 7 observations

10.31 USD_per_person_per_monthThe average financial cost of PrEP provision was $10.31 per person per month.

KenyaVIH/sidaobserved first year of programmatic PrEP deliverypublished 2021BMC health services researchPubMeddocument of 4 observations

18.6 %Site-specific viral rebound rates were 18.6% in Malindi and 18.0% in Meru.

KenyaVIH/sidapublished 2020International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 9 observations

91.2 %91.2% of first incident pregnancies among female sex workers living with HIV in Mombasa, Kenya were unintended.

KenyaVIH/sidaobserved October 2012-April 2017published 2020Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 10 observations

48.8 %A total of 1386 individuals died, and 48.8% were people with HIV in western Kenya.

KenyaVIH/sidapublished 2026Global health actionPubMeddocument of 7 observations

58 %The proportion of adolescents and young people living with HIV on first-line antiretroviral therapy whose regimens were switched within 2 months of recorded unsuppressed viral load results rose from 58% at baseline to 94% during the implementation period.

KenyaVIH/sidaobserved baselinepublished 2022BMJ open qualityPubMeddocument of 8 observations

98.3 %The positive predictive value of dual positive rapid HIV test results was 98.3%.

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

94.4 %Scaled-up PITC resulted in 94.4% of persons living with HIV (PLWH) knowing their status.

KenyaVIH/sidapublished 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 9 observations

22 %Among children who were unsuppressed at baseline, three-month multimonth dispensing (3MMD) was associated with a 22% higher likelihood of retention at 6 months (adjusted risk ratio 1.22, 95% CI: 1.02 to 1.46).

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 8 observations

16.5 %Self-appraised likely HIV exposures were reported by 16.5% of PrEP-eligible adolescent girls and young women (AGYW) in Kenya.

KenyaVIH/sidaobserved 2016/2017published 2024BMC public healthPubMeddocument of 10 observations

28.5 %Among HIV-infected patients enrolled in the program in Central Kenya, those in WHO clinical stage III decreased from 28.5% in 2004 to 10.8% in 2014.

KenyaVIH/sidaobserved 2004 to 2014published 2021BMC infectious diseasesPubMeddocument of 10 observations

83.3 %Among maternal caregivers of HIV-positive children, 110 out of 132 (83.3%) attended antenatal care.

KenyaVIH/sidaobserved 2017-2018published 2020PloS onePubMeddocument of 8 observations

0.85 aHRClinical decision support systems were marginally associated with reduced time from enrollment to first documentation of loss to follow-up, with an adjusted hazard ratio of 0.85.

KenyaVIH/sidaobserved between Sept 1, 2012 and Jan 31, 2014published 2021BMC medical informatics and decision makingPubMeddocument of 5 observations

0 participantsNo participants had virological failure in the oral therapy group.

KenyaVIH/sidapublished 2024The Lancet. Infectious diseasesPubMeddocument of 10 observations

1.106 odds_ratioThe odds of being virally suppressed were increased by IL-10 (OR = 1.106, 95% CI: 0.675–1.811) in HIV-1 participants on first-line cART.

KenyaVIH/sidapublished 2025The Pan African medical journalPubMeddocument of 11 observations

34 %Thirty-four percent of adolescent girls and young women with moderate-to-severe depression had a high HIV risk score corresponding to 5 to 15 incident HIV cases per 100 person-years.

Kenyamoderate-to-severe depression · VIH/sidaobserved January to June 2019published 2020International journal of STD & AIDSPubMeddocument of 4 observations